91 related articles for article (PubMed ID: 15073997)
1. Peripheral vasodilators and the management of peripheral vascular disease and Raynaud's syndrome in general practice.
Connolly JP; McGavock H; Wilson-Davis K
Pharmacoepidemiol Drug Saf; 1998 May; 7(3):189-96. PubMed ID: 15073997
[TBL] [Abstract][Full Text] [Related]
2. Prescribing practice of general practitioners in Northern Ireland for peripheral arterial disease.
Badger SA; Soong CV; Lee B; Swain GR; McGuigan KE
Angiology; 2008; 59(1):57-63. PubMed ID: 18319223
[TBL] [Abstract][Full Text] [Related]
3. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cervicothoracic sympathectomy versus conservative management in patients suffering from incapacitating Raynaud's syndrome after frost bite.
Khan MI; Tariq M; Rehman A; Zafar A; Sheen SN
J Ayub Med Coll Abbottabad; 2008; 20(2):21-4. PubMed ID: 19385450
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Raynaud's phenomenon.
García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
[TBL] [Abstract][Full Text] [Related]
6. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
Béraut E; Cambou JP; Guilhem JM; Vaysse N; Labro S; Séverac D; Boccalon H; Bura-Rivière A
J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Raynaud's phenomenon.
Herrick AL
Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
[TBL] [Abstract][Full Text] [Related]
8. Anorexia nervosa and Raynaud's phenomenon: a case report.
Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
[TBL] [Abstract][Full Text] [Related]
9. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
12. Chromosome aberrations in Raynaud's phenomenon.
Porciello G; Scarpato R; Storino F; Migliore L; Ferri C; Cagetti F; Morozzi G; Bellisai F; Marcolongo R; Galeazzi M
Eur J Dermatol; 2004; 14(5):327-31. PubMed ID: 15358572
[TBL] [Abstract][Full Text] [Related]
13. Time to diagnosis in systemic sclerosis: is sex a factor?
Hudson M; Thombs B; Baron M;
Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
[TBL] [Abstract][Full Text] [Related]
14. Smoking, alcohol consumption, and Raynaud's phenomenon in middle age.
Suter LG; Murabito JM; Felson DT; Fraenkel L
Am J Med; 2007 Mar; 120(3):264-71. PubMed ID: 17349450
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system mediators and Raynaud's phenomenon.
Wood HM; Ernst ME
Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
[TBL] [Abstract][Full Text] [Related]
16. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
17. [Secondary Raynaud's syndrome: skin blood flow decrease between the ischemic episodes and prolongation of the vasoconstriction during the respiratory maneuvers].
Ortiz-Nieva G; Estañol B; Téllez-Zenteno JF; García-Villa M; Corona-Marco V; Padilla-Rubio J; Cardiel-Ríos MH; García-Ramos G
Arch Cardiol Mex; 2004; 74(3):181-91. PubMed ID: 15559870
[TBL] [Abstract][Full Text] [Related]
18. Treating claudication in 5 words (stop smoking and keep walking) is no longer enough: an audit of risk factor management in patients prescribed exercise therapy in New Zealand.
Kuiper N; Gordon M; Roake J; Lewis D
N Z Med J; 2006 Mar; 119(1231):U1918. PubMed ID: 16582978
[TBL] [Abstract][Full Text] [Related]
19. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S; Wigley FM
Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
[TBL] [Abstract][Full Text] [Related]
20. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
